Polymorphisms of platelet adhesive receptors: Do they play a role in primary intracerebral hemorrhage?

Cerebrovascular Diseases

Volumn 15, Issue 1-2, 2003, Pages 51-55

  Iniesta, Juan A ^b   Corral, Javier ^b   González Conejero, Rocio ^b   Piqueras, Claudio ^a   Vicente, Vicente ^b,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

Platelets; Polymorphism; Primary intracerebral hemorrhage

Indexed keywords

ALLOANTIGEN; GLYCOPROTEIN IIIA; RECEPTOR;

ADULT; AGE; AGED; ALLELE; ARTICLE; BRAIN HEMORRHAGE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RACE; RISK FACTOR; TANDEM REPEAT; THROMBOCYTE ADHESION; THROMBOSIS;

ADULT; AGED; ANTIGENS, HUMAN PLATELET; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PATIENT SELECTION; PLATELET ADHESIVENESS; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 0037242939     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067126     Document Type: Article

References (28)

1. Ruggeri ZM, Dent JA, Saldivar E: Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999;94:172-178.
2. Nurden AT, George JN: Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders; in Colman RW, Hirsh J, Clowes AW, George JN (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 921-943.
3. Bray PF: Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 2000;7:284-289.
4. Corral J, Rivera J, Gonzalez-Conejero R, Vicente V: The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 1999;39:372-378.
5. López JA, Ludwig EH, McCarthy BJ: Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macro-glycopeptide region. J Biol Chem 1992;267:10055-10061.
6. Nurden AT: Polymorphism of human membrane glycoproteins: Structure and clinical significance. Thromb Haemost 1995;74:345-351.
7. Choudhri TF, Hoh BL, Zerwes HG, Prestigiacomo CJ, Kim SC, Connolly ES Jr, Kottirsch G, Pinsky DJ: Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibition GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 1998;102:1301-1310.
8. Abumiya T, Fitridge R, Mazur C, Copeland BR, Koziol JA, Tschopp JF, Pierschbacher MD, del Zoppo GJ: Integrin alpha (IIb) beta (3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. Stroke 2000;31:1402-1409.
9. Di Paola J, Federici AB, Mannucci PM, Canciani MT, Kritzik M, Kunicki TJ, Nugent D: Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999;93:3578-3582.
10. O'Connor FF, Shields DC, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ: Genetic variation in glycoprotein IIb/IIIa (GP IIb/IIIa) as a determinant of the responses to an oral GP IIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 2001;98:3256-3260.
11. Adams RD, Victor M, Ropper AH: Cerebrovascular diseases; in Adams RD, Victor M, Ropper AH (eds): Principles of Neurology. New York, McGraw-Hill, 1997, pp 777-873.
12. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC: Bernard-Soulier syndrome. Blood 1998;91:4397-4418.
13. George JN, Caen JP, Nurden AT: Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood 1990;75:1383-1395.
14. Memon MA, Blankenship JC, Wood GC, Frey CM, Menapace FJ: Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis of major clinical trials. Am J Med 2000;109:213-217.
15. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ: A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-1094.
16. González-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V: Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998;92:2771-2776.
17. Zhu MM, Weedon J, Clark LT: Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol 2000;86:1000-1005.
18. López JA: The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994;5:97-119.
19. Corral J, Iniesta JA, González-Conejero R, Villalón M, Vicente V: Polymorphisms of clotting factors modify the risk of primary intracranial hemorrhage. Blood 2001;97:2979-2982.
20. Nichols WC, Amano K, Cacheris PM, Figueiredo MS, Michaelides K, Schwaab R, Hoyer L, Kaufman RJ, Ginsburg D: Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood 1996;88:1183-1187.
21. Lindqvist PG, Svensson PJ, Dahlbäck B, Marsál K: Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - a possible evolutionary selection mechanism. Thomb Haemost 1998;79:69-73.
22. Platelet activation and arterial thrombosis. Report of a meeting of Physicians and Scientists, University of Texas Health Science Center at Houston and Texas Heart Institute, Houston. Lancet 1994;344:991-995.
23. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS: Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000;31:1628-1633.
24. Lee DH, Walker IR, Teitel J, et al: Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A. Thromb Haemost 2000;83:387-391.
25. Lindqvist PG, Zoller B, Dahlback B: Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden - an evolutionary advantage? Thromb Haemost 2001;86:1122-1123.
26. Escuriola Ettingshausen C, Halimeh S, Kurnik K, et al: Symptomatic onset of severe hemo-philia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost 2001;85:218-220.
27. Tizzano EF, Soria JM, Coll I, Guzmán B, Cornet M, Altisent C, Martorell M, Domenech M, del Rio E, Fontcuberta J, Baiget M: The prothrombin 20210 A allele influences clinical manifestation of hemophilia A in patients with intron 22 inversion and without inhibitors. Haematologica 2002;87:279-285.
28. Gopel W, Gortner L, Kohlman T, Schultz C, Moller J: Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation. Acta Paediatr 2001;90:1021-1024.